Fingerprint
Dive into the research topics of 'A double-blind, placebo-controlled phase II study of the efficacy and safety of 2,2-dimethylbutyrate (HQK-1001), an oral fetal globin inducer, in sickle cell disease'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically